These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9381046)

  • 1. [Hormone substitution in menopause].
    Keller PJ; Maurer-Major E
    Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of hormone substitution in the postmenopause period].
    Keller PJ
    Schweiz Rundsch Med Prax; 1991 Apr; 80(16):431-4. PubMed ID: 2038641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone substitution in the female climacteric--goals, means, effects].
    Hauser GA
    Ther Umsch; 1990 Dec; 47(12):970-84. PubMed ID: 2096481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
    Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopause and estrogen replacement therapy.
    Stuenkel CA
    Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone substitution in postmenopause. Administration mode, regimen and compliance].
    Keller PJ
    Zentralbl Gynakol; 1997; 119(6):260-4. PubMed ID: 9312960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of osteoporosis using hormone substitution].
    Keller PJ
    Schweiz Rundsch Med Prax; 1992 Nov; 81(46):1401-4. PubMed ID: 1439425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone replacement therapy].
    Nozue E
    Nihon Rinsho; 1994 Mar; 52(3):787-92. PubMed ID: 8164383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogen substitution therapy in climacteric: should progesterone be omitted in hysterectomized women?].
    Huber J
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):257-61. PubMed ID: 1860657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.